All stock lists
Atrium Therapeutics, Inc. (NASDAQ:RNA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
8.05-0.15 (-1.83%)
Insider Score
––Not scored
RNA Insider Score
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
RNA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New RNA patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RNA from public contracts
Source: USAspending.gov
Recently reported changes in RNA holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing RNA, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for RNA. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.